Quadrant Capital Group’s Insmed INSM Stock Holding History

Quadrant Capital Group’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.43K	Buy	21 +9	+75%	+$1.38K	﹤0.01%	2423
2025 Q4	$2.09K	Hold	12	–	–	﹤0.01%	2516
2025 Q3	$1.73K	Buy	+12	New	+$1.47K	﹤0.01%	2493
2025 Q2	–	Sell	-15	Closed	-$1.15K	–	1952
2025 Q1	$1.15K	Hold	15	–	–	﹤0.01%	2587
2024 Q4	$1.04K	Hold	15	–	–	﹤0.01%	2586
2024 Q3	$1.09K	Hold	15	–	–	﹤0.01%	2581
2024 Q2	$1K	Hold	15	–	–	﹤0.01%	2562
2024 Q1	$407	Hold	15	–	–	﹤0.01%	2651
2023 Q4	$465	Hold	15	–	–	﹤0.01%	2623
2023 Q3	$379	Hold	15	–	–	﹤0.01%	2607
2023 Q2	$317	Sell	15 -8	-35%	-$152	﹤0.01%	2624
2023 Q1	$393	Hold	23	–	–	﹤0.01%	2629
2022 Q4	$460	Buy	+23	New	+$445	﹤0.01%	2635
2022 Q1	–	Sell	-6	Closed	–	–	2589
2021 Q4	$0	Sell	6 -24	-80%	-$686	﹤0.01%	2601
2021 Q3	$1K	Buy	+30	New	+$787	﹤0.01%	2323
2020 Q2	–	Sell	-8	Closed	–	–	2303
2020 Q1	$0	Buy	+8	New	+$190	﹤0.01%	2181

Other funds holding INSM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Quadrant Capital Group's INSM Position: Q1 2026 in Review

Quadrant Capital Group increased its Insmed (INSM) stake by 75% in Q1 2026, buying an estimated $1.38K and bringing the position to 21 shares worth $3.43K. The position accounts for ﹤0.01% of the portfolio, ranked #2423.

Quadrant Capital Group first reported a position in INSM in Q1 2020 and has held it in 16 quarters since. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

Quadrant Capital Group held 21 shares of Insmed worth $3.43K as of Q1 2026.
Quadrant Capital Group bought 9 Insmed shares in Q1 2026, an estimated $1.38K.
Insmed made up ﹤0.01% of Quadrant Capital Group's portfolio in Q1 2026, its #2423 holding.
Quadrant Capital Group first reported a position in Insmed in Q1 2020 and has held it in 16 quarters since.
669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.